Table 1.
Characteristics of the Patient Population
| Age, y (average, range) | 43 (13–76) | |
| Sex (% males) | 63 | |
| Ethnicity (%) | ||
| White, non-Latino | 59 | |
| White, Latino | 22 | |
| African American | 16 | |
| Asian | 3 | |
| Diagnosis (number of cases) | ||
| Hematologic malignancy | 44 | |
| Post-allogeneic stem cell transplant | 31 | |
| Aplastic anemia | 18 | |
| Post-allogeneic stem cell transplant | 11 | |
| Solid tumor with autologous stem cell transplant | 13 | |
| Chronic granulomatous disease | 6 | |
| Job's syndrome | 2 | |
| Cryptococcosis | 2 | |
| Coccidioidomycosis | 2 | |
| System lupus erythematosus | 2 | |
| Sickle cell anemia | 2 | |
| Primary immunodeficiency | 2 | |
| Allergic bronchopulmonary aspergillosis | 1 | |
| Mycobacteriosis other than Mycobacterium tuberculosis | 1 | |
| Total | 95 | |
| Weeks of therapy (avg., median, range) | 10.6, 5, 1–80 | |
| Oral therapy at start of study (number patients) | 51 | |